Abstract
This article examines the role of furosemide and ultrafiltration in the treatment of acute heart failure. Furosemide, a loop diuretic, is successfully employed to reduce circulating blood volume and arterial pressure while increasing urea and uric acid excretion. The study compares two methods of furosemide administration: continuous infusion and intermittent injections, highlighting their advantages and limitations. Ultrafiltration, a method for removing excess fluid from the body, presents a promising alternative to diuretic therapy in the treatment of acute heart failure. This method allows for more precise fluid removal, preservation of kidney function, reduction of patient deterioration risks, improvement in their quality of life, and a decrease in diuretic dosages. Data analysis underscores the efficacy of ultrafiltration in managing acute heart failure with fluid overload and offers a perspective for future therapeutic practices.